Precision Optics Appoints Clay Schwabe as VP of Sales and Marketing
08 Julho 2024 - 10:00AM
Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading
designer and manufacturer of advanced optical instruments for the
medical and defense industries, today announced the appointment of
Clay Schwabe, as the Company’s Vice President of Sales and
Marketing.
Mr. Schwabe has over fifteen years of experience
in medical device market access, sales, sales management, global
product marketing, and commercialization. He is an emerging
technologies specialist with experience in early-stage
commercialization of minimally invasive surgical products and
procedures. Most recently, he served as VP Business Development,
Commercial Strategy, CRO, and Market Access of Veranex. From 2021
to 2023, he was VP Sales / Business Development – Early Commercial
and Market access for PRIA Healthcare where he built out the
business development team to include sales operations, marketing,
and field operations. From 2016 to 2021 he was an Area Manager with
Vertiflex, which was acquired by Boston Scientific in 2019, and
from 2007 to 2016 he was the marketing manager and interventional
sales consultant at Medtronic. Mr. Schwabe is a graduate from the
United States Military Academy at West Point having served as a
United States Army Captain, Platoon Leader, Battalion Staff
Officer, Army World Class Athlete Program, and holds a BS in
Systems Engineering.
“We are extremely excited to welcome Clay
Schwabe to the executive team at Precision Optics,” stated Dr. Joe
Forkey, CEO of Precision Optics. “Clay’s entrepreneurial mindset
and experience developing and executing effective strategies in
high growth environments to uncover innovative solutions to
complicated business challenges within the medical device industry,
will serve us and our customers well going forward.”
The Company’s current SVP of Sales and
Marketing, Jeff DiRubio, will transition out of his role as a
full-time employee to a consulting role where he will continue to
advise the company on product development, marketing, business
development and overall strategic planning for the company.
“I want to thank Jeff for his tremendous
contribution to Precision Optics for over ten years. During this
time, we have increased sales by more than 700% as we have
leveraged our unique micro-optics and digital imaging capabilities
to drive innovation across the medical device and aerospace/defense
industries. I am pleased that Jeff has agreed to continue in a
consulting role and look forward to Jeff’s continued contributions
to the Company.”
About Precision Optics
CorporationFounded in 1982, Precision Optics is a
vertically integrated optics company primarily focused on
leveraging its proprietary micro-optics and 3D imaging technologies
to the healthcare and defense/aerospace industries by providing
services ranging from new product concept through mass manufacture.
Utilizing its leading-edge in-house design, prototype, regulatory
and fabrication capabilities as well as its Lighthouse Imaging
division's electronic imaging expertise and its Ross Optical
division's high volume world-wide sourcing, inspecting and
production resources, the Company designs and manufactures
next-generation product solutions for the most challenging customer
requirements. Within healthcare, Precision Optics enables next
generation medical device companies around the world to meet the
increasing demands of the surgical community who require more
enhanced and smaller imaging systems for minimally invasive
surgery, including single-use medical devices, as well as 3D
endoscopy systems to support the rapid proliferation of surgical
robotic systems. In addition to these next generation applications,
Precision Optics has supplied top tier medical device companies
with a wide variety of optical products for decades, including
complex endocouplers and specialized endoscopes. The Company is
also leveraging its technical proficiency in micro-optics to enable
leading edge defense/aerospace applications which require the
highest quality standards and the optimization of size, weight and
power. For more information, please visit www.poci.com.
About Forward-Looking
StatementsThis press release contains forward-looking
statements. Forward-looking statements include, but are not limited
to, statements that express the Company's intentions, beliefs,
expectations, strategies, predictions or any other statements
related to the Company's future activities or future events or
conditions. These statements are based on current expectations,
estimates and projections about the Company's business based, in
part, on assumptions made by the Company's management. These
statements are not guarantees of future performance and involve
risks, uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results may differ materially from
what is expressed or forecasted in the forward-looking statements
due to numerous risk factors. Any forward-looking statements speak
only as of the date on which they are made, and the Company does
not undertake any obligation to update any forward-looking
statement, except as required by law.
Company Contact: PRECISION
OPTICS CORPORATION22 East BroadwayGardner, Massachusetts
01440-3338Telephone: 978-630-1800
Investor Contact:LYTHAM
PARTNERS, LLCRobert BlumTelephone:
602-889-9700poci@lythampartners.com
Precision Optics (NASDAQ:POCI)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Precision Optics (NASDAQ:POCI)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025